This page is intended for patients who have been prescribed Testogel 16.2mg/g gel

intended for patients prescribed Testogel 16.2mg/g gel

Intended for patients prescribed Testogel 16.2mg/g gel

Patient Information Leaflet

Please read the Patient Information Leaflet for detailed instructions before using your treatment. The Summary of Product Characteristics provides information that may be more relevant to your health care professional.

ADVERSE EVENT REPORTING

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in thisĀ package leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

This page is intended for patients who have been prescribed Testogel 16.2mg/g gel

intended for patients prescribed Testogel 16.2mg/g gel

Ā© 2018 BESINS HEALTHCARE LTD. bhuk/2018/276E Date of Preparation November 2018.

API